Epidermal growth factor improves intestinal adaptation during somatostatin administration in vivo

Journal of Surgical Research

Volumn 63, Issue 1, 1996, Pages 163-168

  Liu, Carson D ^a   Rongione, Anthony J ^a   Shin, Michael S ^a   Ashley, Stanley W ^a   Mcfadden, David W ^a  

^a UCLA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR; GLUCOSE TRANSPORTER; MESSENGER RNA; OCTREOTIDE; RIBONUCLEASE; SODIUM GLUCOSE COTRANSPORTER; SOMATOSTATIN; UNCLASSIFIED DRUG; UROGASTRONE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; COMBINATION CHEMOTHERAPY; CONFERENCE PAPER; CONTROLLED STUDY; DRUG EFFICACY; DRUG POTENTIATION; FEMALE; HISTOPATHOLOGY; INTESTINE ABSORPTION; INTESTINE ADAPTATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SHORT BOWEL SYNDROME; SUBCUTANEOUS DRUG ADMINISTRATION;

EID: 0029890231     PISSN: 00224804     EISSN: None     Source Type: Journal    
DOI: 10.1006/jsre.1996.0241     Document Type: Conference Paper

References (28)

1. Jeejeebhoy, K. N. Therapy of the short gut syndrome. Lancet: 1427, 1983.
2. Gyr, K. E., and Meier, R. Pharmacodynamic effects of sandostatin in the gastrointestinal tract. Metabolism 41: 17, 1992.
3. Lucey, M. R., and Yamada, T. Biochemistry and physiology of gastrointestinal somatostatin. Dig. Dis. Sci. 34: 5S, 1989.
4. Strange, E. F., Schneider, A., Schusdiarra, V., and Ditschuneit, H. Inhibitory effects of somatostatin on growth and differentiation in cultured intestinal mucosa. Horm. Metab. Res. 16: 74, 1984.
5. Bass, B. L., Fischer, B. A., Richardson, C., and Harmon, J. W. Somatostatin analogue treatment inhibits post-resectional adaptation of the small bowel in rats. Am. J. Surg. 161: 107, 1991.
6. Richards, W. O., Geer, R., O'Dorisio, T. M., et al. Octreotide acetate induces fasting small bowel motility in patients with dumping syndrome. J. Surg. Res. 49: 483, 1990.
7. Anthone, G. J., Bastidas, J. A., Orandle, M. S., and Yeo, C. J. Direct proabsorptive effect of octreotide on ionic transport in the small intestine. Surgery 108: 11336, 1990.
8. Paran, H., Neufeld, D., Kaplan, O., et al. Octreotide for treatment of postoperative alimentary tract fistulas. World J. Surg. 19: 430, 1995.
9. Torres-Garcia, A. J., Arguello, J. M., and Balibrea, J. L. Gastrointestinal fistulas: pathology and prognosis. Scand. J. Gastroenterol. 207: 39, 1994.
10. Lennard-Jones, J. E. Review article: practical management of the short bowel. Aliment. Pharmacol. Ther. 8: 563, 1994.
11. Curtin, J. P., and Burt, L. L. Successful treatment of small intestine fistula with somatostatin analog. Gynecol. Oncol. 39: 225, 1990.
12. Nwariaku, F. E., Terracina, A., Mileski, W. J., et al. Is octreotide beneficial following pancreatic injury? Am. J. Surg. 170: 582, 1995.
13. Kocak, S., Bumin, C., Karayalcin, K., et al. Treatment of external biliary, pancreatic and intestinal fistulas with somatostatin analog. Dig. Dis. 12: 62, 1994.
14. Blay, J., and Brown, K. D. Epidermal growth factor promotes the chemotactic migration of cultured rat intestinal epithelial cells. J. Cell. Physiol. 124: 107, 1985.
15. Thompson, J. S., Saxena, S. K., Greaton, C., et al. The effect of route of delivery of urogastrone on intestinal regeneration. Surgery 106: 45, 1989.
16. Saxena, S. K., Thompson, J. S., and Sharp, J. G. Role of epidermal growth factor in intestinal regeneration. Surgery 111: 3318, 1992.
17. Hodin, R., Saldinger, P., and Meng, S. Small bowel adaptation: counterregulatory effects of epidermal growth factor and somatostatin on the program of early gene expression. Surgery 118: 206, 1995.
18. Hoyt, D. W., Harkins, R. N., Debanne, M. T., et al. Interaction of transforming growth factor alpha with the epidermal growth factor receptor: binding kinetics and differential mobility within the bound TGF alpha. Biochemistry 33: 15283, 1994.
19. Thompson, J. S., Nguyen, B. L. T., and Harty, R. F. Somatostatin analogue inhibits intestinal regeneration. Arch. Surg. 128: 385, 1993.
20. Hines, O. J., Bilchik, A. J., McFadden, D. W., et al. Up-regulation of Na+,K+ adenosine triphosphatase after massive intestinal resection. Surgery 116: 401, 1994.
21. Hines, O. J., Bilchik, A. J., Zinner, M. J., et al. Adaptation of the Na+/glucose cotransporter following intestinal resection. J. Surg. Res. 57: 22, 1994.
22. Chirgwin, J. M., Przybyla, A. E., MacDonald, R. J., and Rutter, R. J. Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. Biochemistry 18: 1594, 1979.
23. Lee, J. J., and Costlow, N. A. A molecular titration assay to measure transcript prevalence levels. Methods Enzymol. 152: 63, 1987.
24. Dudrick, S. J., and Latifi, R. Management of short bowel syndrome. Surg. Clin. North. Am. 71: 625, 1991.
25. Grosfeld, J. L., and Rescorla, F. J. Current management of short bowel syndrome in children. J. Ark. Med. Soc. 84: 243, 1987.
26. Armstrong, W. M. Cellular Mechanisms of Ion Transport in the Small Intestine. New York: Raven Press, 1987.
27. O'Keefe, S. J. D., Haymond, M. W., Bennet, W. M., et al. Long-acting somatostatin analogue therapy and protein metabolism in patients with jejunostomies. Gastroenterology 107: 379, 1994.
28. Reubi, J. C., Waser, B., Schmassmann, A., and Halter, F. Persistent lack of somatostatin receptors in gastric mucosa of healing ulcers in rats. Gastroenterology 107: 339, 1994.